VKH
AUPH icon

Virtu KCG Holdings’s Aurinia Pharmaceuticals AUPH Stock Holding History

Virtu KCG Holdings’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$248K Sell
40,460
-64,486
-61% -$435K 0.01% 1906
2017
Q1 		$770K Buy
104,946
+92,465
+741% +$427K 0.02% 938
2016
Q4 		$26K Sell
12,481
-38,391
-75% -$124K ﹤0.01% 3203
2016
Q3 		$153K Buy
+50,872
New +$137K ﹤0.01% 2491

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Virtu KCG Holdings's AUPH Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Aurinia Pharmaceuticals (AUPH) stake by 61% in Q2 2017, selling an estimated $435K and leaving 40,460 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #1906.

Virtu KCG Holdings first reported a position in AUPH in Q3 2016 and has held it in 4 quarters since. The position peaked at $770K in Q1 2017. 65 funds tracked by Wall St. Rank hold AUPH as of Q2 2017.

  • Virtu KCG Holdings held 40,460 shares of Aurinia Pharmaceuticals worth $248K as of Q2 2017.
  • Virtu KCG Holdings sold 64,486 Aurinia Pharmaceuticals shares in Q2 2017, an estimated $435K.
  • Aurinia Pharmaceuticals made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1906 holding.
  • Virtu KCG Holdings first reported a position in Aurinia Pharmaceuticals in Q3 2016 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Aurinia Pharmaceuticals position peaked at $770K in Q1 2017.
  • 65 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.